NEW YORK (Reuters Health) – In patients with blood cancers who contract COVID-19, CD8 T cells may fight the infection when B cells and antibodies are depleted by drug treatment, researchers suggest.
“We...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok